13 Followers on Owler

InflaRx

is a Germany-based biopharmaceutical company that develops monoclonal antibodies for the treatment of inflammatory diseases... Read more
OverviewCompetitorsFundingNews & Insights

InflaRx

is a Germany-based biopharmaceutical company that develops monoclonal antibodies for the treatment of inflammatory diseases... Read more
InflaRx Founder & CEO: Niels C. Riedemann

Founder & CEO

Niels C. Riedemann

CEO Approval Rating

90/100

2007

PublicNASDAQIFRX

Pharmaceuticals & Biotechnology
Pharmaceuticals
28362834 NAICS listing

Annual Revenue
$ < 1M
Employees
66
Funding
$294.9M

News

Conference Presentation
Feb 25, 2025
Benzinga
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences
Funding
Feb 19, 2025
GlobeNewswire
InflaRx received $30M in Post-IPO Equity Funding

InflaRx Competitors

1Akari Therapeutics
2ChemoCentryx
3Alnylam
4XBiotech
5Kymab
6XOMA Royalty
7Alder BioPharmaceuticals
8Novartis
9NovImmune
10Regeneron
Unlock 18 + competitors

Trending Companies